Effectiveness of a bivalent Haemophilus influenzae type B-hepatitis B vaccine in preventing hepatitis B virus infection among children born to hepatitis B e antigen-positive carrier mothers

Richard Ralph Doherty, Suzanne M Garland, Martin Wright, Monique Bulotsky, Charles Liss, Hassan Lakkis, Alexander Nikas, Walter Straus

Research output: Contribution to journalArticleResearchpeer-review

Abstract

This observational study evaluated a modified immunoprophylactic regimen (hepatitis B immune globulin [HBIG]) and a dose of thimerosal-free monovalent hepatitis B (HB) vaccine shortly after birth followed by doses of thimerosal-free bivalent Haemophilus influenzae type b (Hib)-HB vaccine at 2 and 4 months of age, and a booster at 12 months of age) in infants at high risk of hepatitis B virus (HBV) infection (mothers HBeAg+).
Original languageEnglish
Pages (from-to)777 - 781
Number of pages5
JournalPediatric Infectious Disease Journal
Volume28
Issue number9
DOIs
Publication statusPublished - 2009

Cite this

Doherty, Richard Ralph ; Garland, Suzanne M ; Wright, Martin ; Bulotsky, Monique ; Liss, Charles ; Lakkis, Hassan ; Nikas, Alexander ; Straus, Walter. / Effectiveness of a bivalent Haemophilus influenzae type B-hepatitis B vaccine in preventing hepatitis B virus infection among children born to hepatitis B e antigen-positive carrier mothers. In: Pediatric Infectious Disease Journal. 2009 ; Vol. 28, No. 9. pp. 777 - 781.
@article{1e2e00fd3f234a5baaf96f35cea4935f,
title = "Effectiveness of a bivalent Haemophilus influenzae type B-hepatitis B vaccine in preventing hepatitis B virus infection among children born to hepatitis B e antigen-positive carrier mothers",
abstract = "This observational study evaluated a modified immunoprophylactic regimen (hepatitis B immune globulin [HBIG]) and a dose of thimerosal-free monovalent hepatitis B (HB) vaccine shortly after birth followed by doses of thimerosal-free bivalent Haemophilus influenzae type b (Hib)-HB vaccine at 2 and 4 months of age, and a booster at 12 months of age) in infants at high risk of hepatitis B virus (HBV) infection (mothers HBeAg+).",
author = "Doherty, {Richard Ralph} and Garland, {Suzanne M} and Martin Wright and Monique Bulotsky and Charles Liss and Hassan Lakkis and Alexander Nikas and Walter Straus",
year = "2009",
doi = "10.1097/INF.0b013e3181a06fad",
language = "English",
volume = "28",
pages = "777 -- 781",
journal = "Pediatric Infectious Disease Journal",
issn = "0891-3668",
publisher = "Lippincott Williams & Wilkins",
number = "9",

}

Effectiveness of a bivalent Haemophilus influenzae type B-hepatitis B vaccine in preventing hepatitis B virus infection among children born to hepatitis B e antigen-positive carrier mothers. / Doherty, Richard Ralph; Garland, Suzanne M; Wright, Martin; Bulotsky, Monique; Liss, Charles; Lakkis, Hassan; Nikas, Alexander; Straus, Walter.

In: Pediatric Infectious Disease Journal, Vol. 28, No. 9, 2009, p. 777 - 781.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - Effectiveness of a bivalent Haemophilus influenzae type B-hepatitis B vaccine in preventing hepatitis B virus infection among children born to hepatitis B e antigen-positive carrier mothers

AU - Doherty, Richard Ralph

AU - Garland, Suzanne M

AU - Wright, Martin

AU - Bulotsky, Monique

AU - Liss, Charles

AU - Lakkis, Hassan

AU - Nikas, Alexander

AU - Straus, Walter

PY - 2009

Y1 - 2009

N2 - This observational study evaluated a modified immunoprophylactic regimen (hepatitis B immune globulin [HBIG]) and a dose of thimerosal-free monovalent hepatitis B (HB) vaccine shortly after birth followed by doses of thimerosal-free bivalent Haemophilus influenzae type b (Hib)-HB vaccine at 2 and 4 months of age, and a booster at 12 months of age) in infants at high risk of hepatitis B virus (HBV) infection (mothers HBeAg+).

AB - This observational study evaluated a modified immunoprophylactic regimen (hepatitis B immune globulin [HBIG]) and a dose of thimerosal-free monovalent hepatitis B (HB) vaccine shortly after birth followed by doses of thimerosal-free bivalent Haemophilus influenzae type b (Hib)-HB vaccine at 2 and 4 months of age, and a booster at 12 months of age) in infants at high risk of hepatitis B virus (HBV) infection (mothers HBeAg+).

UR - http://journals.lww.com/pidj/Abstract/2009/09000/Effectiveness_of_a_Bivalent_Haemophilus_influenzae.5.aspx

U2 - 10.1097/INF.0b013e3181a06fad

DO - 10.1097/INF.0b013e3181a06fad

M3 - Article

VL - 28

SP - 777

EP - 781

JO - Pediatric Infectious Disease Journal

JF - Pediatric Infectious Disease Journal

SN - 0891-3668

IS - 9

ER -